Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 2.
Figure 2.

Response to the acute dose of acetaminophen in a panel of mouse strains. (A) Representative photomicrographs (100×) of the hematoxylin and eosin-stained sections of left liver lobe of mice 24 h after dosing with acetaminophen (300 mg/kg). (B) Liver necrosis score (mean ± SE, n = 3–4/strain) in mice treated with acetaminophen (300 mg/kg) for 24 h. (C) Serum ALT levels (mean ± SE) in acetaminophen-treated mice sacrificed 24 h after dosing. (D) Serum ALT levels (mean ± SE) in acetaminophen-treated mice sacrificed 4 h post-dosing. (E) Liver reduced glutathione (ratio between acetaminophen- and vehicle-treated animals in each strain, mean ± SE) 4 h post-dosing. (Graphic) Strains with no data. (F) Dose-response to acetaminophen-induced liver injury as measured by ALT release (n = 4/strain, mean ± SE) at 24 h after treatment.

This Article

  1. Genome Res. 19: 1507-1515

Preprint Server